Citation Impact
Citing Papers
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2018
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Management education and development : drift or thrust into the 21st century?
1988 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
2012
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy
2021
Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation
2011
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Cardiac Magnetic Resonance Detection of Myocardial Scarring in Hypertrophic Cardiomyopathy
2009
Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
2012
Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively
2013
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
NOVEL MITOCHONDRIAL DNA MUTATIONS ASSOCIATED WITH CHINESE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
2009 StandoutNobel
Left Ventricular Outflow Tract Obstruction as a Risk Factor for Sudden Cardiac Death in Hypertrophic Cardiomyopathy
2009
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
2010
Clinical Implications of Midventricular Obstruction in Patients With Hypertrophic Cardiomyopathy
2011
Amyloid Heart Disease
2010
Environmental and Health Impacts of Air Pollution: A Review
2020 Standout
Genetics of Hypertrophic Cardiomyopathy After 20 Years
2012
Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance
2012
Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy
2012
Differentiating Left Ventricular Hypertrophy in Athletes from That in Patients With Hypertrophic Cardiomyopathy
2014
Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy
2021
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease
2013 Standout
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
2010
Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy
2010
Assessment of Left Ventricular Hypertrophy in a Trained Athlete: Differential Diagnosis of Physiologic Athlete's Heart From Pathologic Hypertrophy
2012
Current management of hypertrophic cardiomyopathy
2008
Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
2008
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
2010
Safety and tolerability of prescription omega-3 fatty acids: A systematic review and meta-analysis of randomized controlled trials
2018
Noninvasive Detection of Fibrosis Applying Contrast-Enhanced Cardiac Magnetic Resonance in Different Forms of Left Ventricular Hypertrophy
2009
Amyloid heart disease: a brief review of treatment options
2012
Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging
2012
Management Implications of Massive Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy Significantly Underestimated by Echocardiography but Identified by Cardiovascular Magnetic Resonance
2010
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Hypertrophic cardiomyopathy
2012
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
2015 Standout
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
2012
Hypertrophic Cardiomyopathy
2014
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
2012
Myocarditis
2011 Standout
Bladder cancer
2016 Standout
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
2010
Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations
2011
Systemic amyloidosis
2015 Standout
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
2009
Novel Hypertrophic Cardiomyopathy Phenotype: Segmental Hypertrophy Isolated to the Posterobasal Left Ventricular Free Wall
2010
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Usefulness of Magnetic Resonance Imaging to Distinguish Hypertensive and Hypertrophic Cardiomyopathy
2010
Update on Myocarditis
2012 Standout
Incidence and Causes of Sudden Death in U.S. College Athletes
2014
MRI in acute myocardial infarction
2010
Myocardial Fibrosis Severity on Cardiac Magnetic Resonance Imaging Predicts Sustained Arrhythmic Events in Hypertrophic Cardiomyopathy
2012
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy
2009
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
2011
Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy
2013
American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy
2011
Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death
2009
Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography
2018 Standout
Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry
2016
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
2010
Distinguishing hypertrophic cardiomyopathy from athlete’s heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening
2009
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial
2012
Nonsustained Ventricular Tachycardia
2012
Sudden Death in Hypertrophic Cardiomyopathy
2009
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy
2009
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction
2013
Matrix Rigidity Controls Endothelial Differentiation and Morphogenesis of Cardiac Precursors
2012 StandoutNobel
Review: Update on Newer Antihypertensive Medicines and Interventions
2010
Prognosis Assessment of Cardiac Involvement in Systemic AL Amyloidosis by Magnetic Resonance Imaging
2010
Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association
2015
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
2010
Patterns of Disease Progression in Hypertrophic Cardiomyopathy
2012
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Outcome of Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in Children and Young Adults
2012
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy
2008
Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
2010
Prediction of Sarcomere Mutations in Subclinical Hypertrophic Cardiomyopathy
2014
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction
2020
Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers Without Left Ventricular Hypertrophy
2013
Transthyretin (TTR) Cardiac Amyloidosis
2012
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
Machine learning-based approach: global trends, research directions, and regulatory standpoints
2021 Standout
Relationship of Delayed Enhancement by Magnetic Resonance to Myocardial Perfusion by Positron Emission Tomography in Hypertrophic Cardiomyopathy
2013
Long-Term Outcomes of Combined Epicardial and Endocardial Ablation of Monomorphic Ventricular Tachycardia Related to Hypertrophic Cardiomyopathy
2011
Direct Renin Inhibitors as a New Therapy for Hypertension
2010
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
Investigation of Global and Regional Myocardial Mechanics With 3-Dimensional Speckle Tracking Echocardiography and Relations to Hypertrophy and Fibrosis in Hypertrophic Cardiomyopathy
2013
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly
2016
Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
2010
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Clinical Characteristics and Natural History of Hypertrophic Cardiomyopathy With Midventricular Obstruction
2013
Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy
2010
Direct renin inhibition: An update
2009
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2017
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
Works of Evan Appelbaum being referenced
Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy
2011
Abstract 14979: Progressive Heart Failure is Uncommon in Patients With Nonobstructive Hypertrophic Cardiomyopathy
2013
Abstract 13294: Evidence for Reduced Mortality in an Adult Cohort With Hypertrophic Cardiomyopathy
2013
2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
2008
Relation Between Infarct Size in ST-Segment Elevation Myocardial Infarction Treated Successfully by Percutaneous Coronary Intervention and Left Ventricular Ejection Fraction Three Months After the Infarct
2010
Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance
2009
Hypertrophic Cardiomyopathy: Quantification of Late Gadolinium Enhancement with Contrast-enhanced Cardiovascular MR Imaging
2010
Spectrum and Clinical Significance of Systolic Function and Myocardial Fibrosis Assessed by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
2010
Significance of False Negative Electrocardiograms in Preparticipation Screening of Athletes for Hypertrophic Cardiomyopathy
2012
Significance of Papillary Muscle Abnormalities Identified by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
2007
Diagnostic and Prognostic Utility of Cardiovascular Magnetic Resonance Imaging in Light-Chain Cardiac Amyloidosis
2008
Sudden Cardiac Arrest in Hypertrophic Cardiomyopathy in the Absence of Conventional Criteria for High Risk Status
2007
Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance
2008
Obesity and its Association to Phenotype and Clinical Course in Hypertrophic Cardiomyopathy
2013
Relation Between Myocardial Infarct Size and Ventricular Tachyarrhythmia Among Patients With Preserved Left Ventricular Ejection Fraction Following Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction
2009
Significance of left ventricular apical–basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy
2014
Association of TIMI Myocardial Perfusion Grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction
2008
Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
2009
Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy
2012
PREVALENCE AND CLINICAL PROFILE OF MYOCARDIAL CRYPTS IN HYPERTROPHIC CARDIOMYOPATHY
2011
Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction
2016
Multimodality CMR detection of coronary artery disease in patients with heart failure and depressed systolic function: superiority of coronary MRI compared to late gadolinium enhancement
2010
Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age
2012
Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
2008
Abstract 3097: Significance of Delayed Enhancement with Contrast Enhanced Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
2007
Intermediate-Signal-Intensity Late Gadolinium Enhancement Predicts Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy
2011
Abstract 694: More Extensive Left Ventricular Hypertrophy in Transthyretin-Type Cardiac Amyloidosis as Compared to Primary Light-Chain Cardiac Amyloidosis
2008